Image

FUSE - Feasibility of Patient Held Sensors for Medical Emergencies

FUSE - Feasibility of Patient Held Sensors for Medical Emergencies

Recruiting
All
Phase N/A

Powered by AI

Overview

The investigators want to study how wearable devices can help track health changes in people when they are not feeling well. Normally, clinicians compare someone's vital signs, like heart rate, to average ranges from healthy folks. But what if clinicians compare these signs to the person's own normal when they were well? The investigators aim to check if wearable sensors can make this possible for many people. The investigators will look at heart rate differences when someone is admitted to the hospital compared to their stable days before. The investigators will see how their daily steps change a week before getting sick. This global study involves adults in emergency or acute care. Participation poses no risks, burdens, or immediate benefits to patients.

Description

Rationale

Abnormalities of vital signs are quantified by comparison with 'usual' ranges, which are those observed in resting healthy populations. It might be more appropriate to compare vital sign values of an individual that is in distress with their own usual values recorded when they were stable and well. Wearable sensors might make this possible at scale.

Objectives
  • To quantify the difference between heart rate on admission to acute care compared to the previously recorded vital signs when 24 hours and 1 week prior of the same patient.
  • The change in daily steps taken by the patient in the week prior to admission to acute care
  • To assess the feasibility of using heart rate data from patients' own wearable sensors.

Study design:

An asynchronous, international, multicentre observational study using the Flash Mob Research design.

Study population:

Patients aged 18 years and up who present at the Emergency Department, Acute Medical Department or Ambulatory Emergency Care with an acute complaint.

Main study parameters/endpoints:

  • The difference between heart rate measured on presentation to acute care services, and measured prior when stable and well.
  • The daily number of steps taken in the week prior to presentation to acute care services.
  • The proportion of patients assessed for an acute complaint who have recordings of vital signs measured before they became unwell.
  • A description of the population that uses devices that collect vital signs in terms of sex, age-group, digital literacy, and their severity of illness on presentation (as measured by a standard set of vital signs and frailty).
  • The devices used to measure vital signs before they became unwell, and the vital signs they measure.

Nature and extent of the burden and risks associated with participation, benefit and group

relatedness

There is no burden or risk associated with participation to patients, and no immediate benefit.

Eligibility

Inclusion Criteria:

A subject must meet all the following criteria:

  • Have an acute presenting complaint
  • Aged 18 years or older
  • Uses any of the following: smart-watch, activity tracker, or other wearable monitoring device, a smart phone that collects data from other wearable device
  • Ability to give informed consent

Exclusion Criteria:

  • Unable to give informed consent, including patients with immediately life-threatening illness

Study details
    Medical Emergencies

NCT06199310

Betsi Cadwaladr University Health Board

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.